Annual CFF
$5.45 M
+$4.33 M+389.14%
December 31, 2023
Summary
- As of February 7, 2025, PPBT annual cash flow from financing activities is $5.45 million, with the most recent change of +$4.33 million (+389.14%) on December 31, 2023.
- During the last 3 years, PPBT annual CFF has fallen by -$63.04 million (-92.04%).
- PPBT annual CFF is now -92.04% below its all-time high of $68.49 million, reached on December 31, 2020.
Performance
PPBT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$2.13 M
+$1.70 M+392.84%
September 1, 2024
Summary
- As of February 7, 2025, PPBT quarterly cash flow from financing activities is $2.13 million, with the most recent change of +$1.70 million (+392.84%) on September 1, 2024.
- Over the past year, PPBT quarterly CFF has increased by +$1.87 million (+696.27%).
- PPBT quarterly CFF is now -63.42% below its all-time high of $5.83 million, reached on September 1, 2014.
Performance
PPBT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$7.08 M
+$1.56 M+28.30%
September 1, 2024
Summary
- As of February 7, 2025, PPBT TTM cash flow from financing activities is $7.08 million, with the most recent change of +$1.56 million (+28.30%) on September 1, 2024.
- Over the past year, PPBT TTM CFF has increased by +$1.63 million (+29.86%).
- PPBT TTM CFF is now at all-time high.
Performance
PPBT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
PPBT Cash From Financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +389.1% | +696.3% | +29.9% |
3 y3 years | -92.0% | +275.0% | +370.8% |
5 y5 years | -30.0% | - | - |
PPBT Cash From Financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +389.1% | -49.7% | +2297.8% | at high | +1238.6% |
5 y | 5-year | -92.0% | +389.1% | -49.7% | +3843.9% | at high | +1238.6% |
alltime | all time | -92.0% | +677.3% | -63.4% | +3843.9% | at high | +1238.6% |
Purple Biotech Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $2.13 M(+392.8%) | $7.08 M(+28.3%) |
Jun 2024 | - | $433.00 K(+61.6%) | $5.52 M(+1.2%) |
Mar 2024 | - | $268.00 K(-93.7%) | $5.45 M(+0.1%) |
Dec 2023 | $5.45 M(+389.1%) | $4.25 M(+642.3%) | $5.45 M(+321.7%) |
Sep 2023 | - | $572.00 K(+55.9%) | $1.29 M(+0.2%) |
Jun 2023 | - | $367.00 K(+39.0%) | $1.29 M(+6.0%) |
Mar 2023 | - | $264.00 K(+196.6%) | $1.22 M(+9.2%) |
Dec 2022 | $1.11 M(-26.3%) | $89.00 K(-84.4%) | $1.11 M(-25.9%) |
Sep 2022 | - | $569.00 K(+93.5%) | $1.50 M(+71.3%) |
Jun 2022 | - | $294.00 K(+81.5%) | $878.00 K(+66.0%) |
Mar 2022 | - | $162.00 K(-66.2%) | $529.00 K(-65.0%) |
Dec 2021 | $1.51 M | $479.00 K(-940.4%) | $1.51 M(+46.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2021 | - | -$57.00 K(+3.6%) | $1.03 M(-5.2%) |
Jun 2021 | - | -$55.00 K(-104.8%) | $1.09 M(-4.8%) |
Mar 2021 | - | $1.15 M(-45.7%) | $1.15 M(-45.7%) |
Dec 2020 | $68.49 M(+1208.8%) | - | - |
Dec 2019 | $5.23 M(-32.8%) | - | - |
Dec 2018 | $7.79 M(+160.0%) | - | - |
Dec 2017 | $3.00 M(-70.9%) | - | - |
Dec 2016 | $10.29 M(-18.6%) | - | - |
Dec 2015 | $12.63 M(+117.0%) | - | - |
Sep 2015 | - | $2.11 M(-63.9%) | $2.11 M(-63.9%) |
Dec 2014 | $5.82 M(+730.5%) | - | - |
Sep 2014 | - | $5.83 M | $5.83 M |
Dec 2013 | $701.00 K | - | - |
FAQ
- What is Purple Biotech annual cash flow from financing activities?
- What is the all time high annual CFF for Purple Biotech?
- What is Purple Biotech annual CFF year-on-year change?
- What is Purple Biotech quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Purple Biotech?
- What is Purple Biotech quarterly CFF year-on-year change?
- What is Purple Biotech TTM cash flow from financing activities?
- What is the all time high TTM CFF for Purple Biotech?
- What is Purple Biotech TTM CFF year-on-year change?
What is Purple Biotech annual cash flow from financing activities?
The current annual CFF of PPBT is $5.45 M
What is the all time high annual CFF for Purple Biotech?
Purple Biotech all-time high annual cash flow from financing activities is $68.49 M
What is Purple Biotech annual CFF year-on-year change?
Over the past year, PPBT annual cash flow from financing activities has changed by +$4.33 M (+389.14%)
What is Purple Biotech quarterly cash flow from financing activities?
The current quarterly CFF of PPBT is $2.13 M
What is the all time high quarterly CFF for Purple Biotech?
Purple Biotech all-time high quarterly cash flow from financing activities is $5.83 M
What is Purple Biotech quarterly CFF year-on-year change?
Over the past year, PPBT quarterly cash flow from financing activities has changed by +$1.87 M (+696.27%)
What is Purple Biotech TTM cash flow from financing activities?
The current TTM CFF of PPBT is $7.08 M
What is the all time high TTM CFF for Purple Biotech?
Purple Biotech all-time high TTM cash flow from financing activities is $7.08 M
What is Purple Biotech TTM CFF year-on-year change?
Over the past year, PPBT TTM cash flow from financing activities has changed by +$1.63 M (+29.86%)